PHYTOSPAGYRIE N°11 IMMUNITÉ ALLERGÈNES
Food supplement declared in France, declaration No 2019-4-678
PHYTOSPAGYRIE N°11 IMMUNITÉ ALLERGÈNES (HERBIER DU VELAY) is a food supplement declared in France. Status: withdrawn from the market on 19 January 2023. Main ingredients: Ribes nigrum 375 mg per day, Matricaria chamomilla 375 mg per day, Pinus sylvestris 375 mg per day, Plantago major 375 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- HERBIER DU VELAY
- Food business operator placing the product on the market
- SAS VECTEUR ENERGY
- Status
- Withdrawn from the market on 19 January 2023
- Form
- Bottle
- Daily dose
- 10
- Directions for use
- Prendre 5 ml (1 cuillère à café) matin et soir, à diluer dans 5 à 10 volumes d'eau. Agiter avant uti
- Objectives stated by the manufacturer (these are not authorised claims)
- Immunity
Declaration 212865, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Ribes nigrum L. | Feuille | Macérât hydroglycériné | 375 mg |
| Matricaria chamomilla L. | Parties aériennes | Macérât hydroglycériné | 375 mg |
| Pinus sylvestris L. | Bourgeon | Macérât hydroglycériné | 375 mg |
| Plantago major L. | Parties aériennes | Macérât hydroglycériné | 375 mg |
Additives
E422
Other ingredients
Vitis vinifera L.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Regulatory points
- Information
Withdrawn from the market on 19 January 2023, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Matricaria chamomilla L.
Read the warning, when it applies and the studies cited
GERMAN CHAMOMILE - MATRICARIA CHAMOMILLA Oral
Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000; WHO 1999; Bradley 1992).
Cautions and warnings
When using this product exercise caution if you drive or use machinery as you may experience drowsiness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
- ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. 2003. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Health Canada monograph dated 19 December 2025
German Chamomile - Matricaria Chamomilla Topical
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
- ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Health Canada monograph dated 31 January 2025
GERMAN CHAMOMILE - MATRICARIA CHAMOMILLA Buccal
Route of administration: Buccal (ESCOP 2003; Blumenthal et al. 2000; Bradley 1992)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
- ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- PHYTOSPAGYRIE N°11 IMMUNITÉ ALLERGÈNES HERBIER DU VELAY, declared in 2018, withdrawn from the market : different composition: 2 ingredient(s) added, 2 missing
Brand : HERBIER DU VELAY
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “PHYTOSPAGYRIE N°11 IMMUNITÉ ALLERGÈNES (HERBIER DU VELAY): composition and regulation”, https://compoatlas.com/en/supplements/products/212865-phytospagyrie-n-11-immunite-allergenes, updated 15 November 2026.